We restricted our association tests to non-rare (>1%) CNVs for two reasons. First, the traditional genome wide association study design has little power to detect rare genetic variants (<1%), and the case control study design of this project cannot provide enough power to detect rare CNVs. Second, accuracy of CNV detection diminishes with decreasing frequency.